default author photo

Hiroya Hashimoto

Nagoya City University - Core Laboratory

1 Kawasumi

Mizuho-cho, Mizuho-ku

Nagoya , 467-8601

Japan

SCHOLARLY PAPERS

2

DOWNLOADS

107

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Efficacy and Safety of Carboplatin With Nab-Paclitaxel Versus Docetaxel in Elderly Patients with Squamous-Cell Lung Cancer (CAPITAL): A Randomized, Multicenter, Open-Label, Phase III Trial

Number of pages: 35 Posted: 17 May 2021
National Hospital Organization (NHO) - Department of Respiratory Medicine, Chiba University - Department of Respirology, National Hospital Organization (NHO) - Nagoya Medical Center, National Hospital Organization (NHO) - Nishisaitama-Chuo National Hospital, National Hospital Organization (NHO), Nagoya Medical Center, Clinical Research Center, Nagoya City University - Core Laboratory, National Hospital Organization - Department of Thoracic Oncology, Chiba University - Chiba University Hospital, Iizuka Hospital - Department of Respiratory Oncology, Tohoku University - Department of Palliative Medicine, Kansai Medical University - Kansai Medical University Hospital, Kyushu University, National Hospital Organization (NHO) - Department of Thoracic Oncology, Hokkaido University Hospital - Division of Laboratory and Transfusion Medicine, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Yokohama City University - Department of Biostatistics, Nagoya University - Center for Advanced Medicine and Clinical Research, National Hospital Organization (NHO), Nagoya Medical Center, Clinical Research Center, Nippon Medical School - Department of Pulmonary Medicine and Oncology, National Hospital Organization Kyushu Cancer Center, National Hospital Organization Kyushu Cancer - Department of Thoracic Oncology,, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology and Nippon Medical School
Downloads 57 (989,921)

Abstract:

Loading...

2.

Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study

Number of pages: 26 Posted: 16 Sep 2025
National Hospital Organization Nagoya Medical Center, National Hospital Organization (NHO) - Osaka Toneyama Medical Center, Ogaki Municipal Hospital, National Hospital Organization (NHO), Nagoya Medical Center, Clinical Research Center, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology, Matsunami General Hospital, Fujita Health University, Kanagawa Cardiovascular and Respiratory Center, Hokkaido University Hospital - Division of Laboratory and Transfusion Medicine, Chiba University, affiliation not provided to SSRN, Fujita Health University, affiliation not provided to SSRN, Takarazuka City Hospital, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital and Nagoya City University - Core Laboratory
Downloads 50 (1,063,489)

Abstract:

Loading...

Pembrolizumab, Pemetrexed, non-squamous nons-mall cell lung cancer, PD-L1, older patients